Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer - Turhal, N. S.; Elif Şenocak Taşçı; Başak Oyan; Özlem Sönmez; Arda Ulaş Mutlu; Muhammed Mustafa Atçı; Abdullah Sakin; İrem Öner; Havva Yeşil Çınkır; Melek Karakurt Eryılmaz; Dilek Çağlayan; Onur Yazdan Balçık; et al. (My University, 2024)
Keywords: Regorafenib; Medicine; Colorectal cancer; Internal medicine; Hazard ratio; Chemotherapy; Oncology; Surgical oncology; Placebo; Fluorouracil; Regimen; Bevacizumab; Oxaliplatin; Surgery; Cancer; Confidence interval; Pathology; 3